Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 221,894,049 papers from all fields of science
Search
Sign In
Create Free Account
acexamic acid
Known as:
N-acetylamino-6-hexanoic acid
, 6-(acetylamino)hexanoic acid
, Hexanoic acid, 6-(acetylamino)-
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
6 relations
Broader (2)
Aminocaproates
Anti-Inflammatory Agents, Non-Steroidal
Narrower (4)
NAS-501
Plastenan
sodium acexamate
zinc acexamate
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Allergic contact dermatitis to acexamic acid
A. M. S. Reis
,
Raquel Silva
,
Joao G. Pignatelli
Contact Dermatitis
2008
Corpus ID: 205813174
A 66-year-old woman, with stasis dermatitis, hypertension, and hypercholesterolemia, but no previous story of atopy, has been…
Expand
2004
2004
The effect of the monoamine oxidase inhibitor isocarboxazid on the canine metabolism of the cell-differentiating agent hexamethylene bisacetamide
B. Conley
,
Gerald F. Sewack
,
M. Egorin
,
B. Subramanyam
,
J. Page
,
C. Grieshaber
Cancer Chemotherapy and Pharmacology
2004
Corpus ID: 23320329
SummaryThe acute toxicities of the cellular differentiating agent hexamethylene bisacetamide (HMBA) in humans and animals include…
Expand
1993
1993
Alkylamides as inducers of human leukemia cell differentiation: a quantitative structure-activity relationship study using comparative molecular field analysis.
A. D. Harpalani
,
S. Snyder
,
B. Subramanyam
,
M. Egorin
,
P. Callery
Cancer Research
1993
Corpus ID: 1075221
Computer assisted quantitative structure-activity studies using comparative molecular field analysis (CoMFA) were performed on a…
Expand
1991
1991
Phase I bioavailability and pharmacokinetic study of hexamethylene bisacetamide (NSC 95580) administered via nasogastric tube.
F. T. Ward
,
J. Kelley
,
+4 authors
H. Chun
Cancer Research
1991
Corpus ID: 21213145
A Phase I clinical trial and pharmacological study of nasogastrically administered hexamethylene bisacetamide, a polar-planar…
Expand
1990
1990
Effects of the monoamine oxidase inhibitor, tranylcypromine, on induction of HL60 cell differentiation by hexamethylene bisacetamide and N-acetyl-1,6-diaminohexane.
S. Snyder
,
M. Egorin
,
E. Zuhowski
,
E. C. Schimpff
,
P. Callery
Cancer Communications
1990
Corpus ID: 6305942
Hexamethylene bisacetamide (HMBA) is converted by successive deacetylation and oxidation reactions to four major metabolites; in…
Expand
1989
1989
An active, aldehydic metabolite of the cell-differentiating agent hexamethylene bisacetamide.
B. Subramanyam
,
P. Callery
,
M. Egorin
,
S. Snyder
,
B. Conley
Drug Metabolism And Disposition
1989
Corpus ID: 38542983
6-Acetamidohexanal has been identified in human plasma and urine as a metabolite of the cell-differentiating agent, hexamethylene…
Expand
1988
1988
Induction of differentiation of human promyelocytic leukemia cells (HL60) by metabolites of hexamethylene bisacetamide.
S. Snyder
,
M. Egorin
,
L. Geelhaar
,
A. Hamburger
,
P. Callery
Cancer Research
1988
Corpus ID: 11974622
We studied the ability of five metabolites of hexamethylene bisacetamide (HMBA), which we had previously identified in patient…
Expand
1988
1988
Metabolism of hexamethylene bisacetamide and its metabolites in leukemic cells.
M. Egorin
,
S. Snyder
,
A. Cohen
,
E. Zuhowski
,
B. Subramanyam
,
P. Callery
Cancer Research
1988
Corpus ID: 15697205
We investigated whether leukemic cell lines could convert hexamethylene bisacetamide (HMBA) to any of the metabolites previously…
Expand
1988
1988
Involvement of monoamine oxidase and diamine oxidase in the metabolism of the cell differentiating agent hexamethylene bisacetamide (HMBA).
B. Conley
,
P. Callery
,
M. Egorin
,
B. Subramanyam
,
L. Geelhaar
,
S. Pan
Life Science
1988
Corpus ID: 44615319
1986
1986
Identification of metabolites of the cell-differentiating agent hexamethylene bisacetamide in humans.
P. Callery
,
M. Egorin
,
L. Geelhaar
,
M. Nayar
Cancer Research
1986
Corpus ID: 12693663
Hexamethylene bisacetamide, a compound which in vitro induces differentiation in a wide variety of human and animal cancer cell…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE